Resistance to meropenem-vaborbactam in clinical isolates of Enterobacter roggenkampii without previous exposure to vaborbactam

Clin Microbiol Infect. 2022 Dec;28(12):1662-1664. doi: 10.1016/j.cmi.2022.09.005. Epub 2022 Sep 20.

Affiliations

¹ Servicio de Microbiología, Hospital Universitario La Paz, IdiPAZ, Paseo de La Castellana, Madrid, Spain.
² Servicio de Farmacia, Hospital Universitario La Paz, Paseo de La Castellana, Madrid, Spain.
³ Servicio de Microbiología, Hospital Universitario La Paz, IdiPAZ, Paseo de La Castellana, Madrid, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jesus.mingorance@salud.madrid.org.

PMID: 36150673
DOI: 10.1016/j.cmi.2022.09.005

No abstract available

Publication types

Letter

MeSH terms

Enterobacter*
Humans
Meropenem / pharmacology

Substances

Meropenem
vaborbactam

Supplementary concepts

Enterobacter roggenkampii